Increasing the endogenous NO level causes catalase inactivation and reactivation of intercellular apoptosis signaling specifically in tumor cells

Redox Biology

Volumn 6, Issue , 2015, Pages 353-371

  Bauer, Georg ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Catalase; Intercellular apoptosis inducingsignaling; Nitric oxide; Peroxynitrite; Singlet oxygen; Synergistic effect

Indexed keywords

CATALASE; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE; 5,10,15,20-TETRAKIS(4-SULFONATOPHENYL)PORPHYRINATO IRON(III) CHLORIDE; ACETYLSALICYLIC ACID; FAS ANTIGEN; HYDROGEN PEROXIDE; HYPOCHLOROUS ACID; METALLOPORPHYRIN; N-ACETYL-S-(ALPHA-METHYL-4-(2-METHYLPROPYL)BENZENEACETYL)CYSTEINE 4-(NITROOXY)BUTYL ESTER; NITRIC ACID DERIVATIVE; PEROXYNITROUS ACID; PROTON PUMP; SINGLET OXYGEN;

ADENOCARCINOMA CELL LINE; ADULT; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DECOMPOSITION; DNA STRAND BREAKAGE; ENZYME INACTIVATION; ENZYME INHIBITION; ENZYME REACTIVATION; FEMALE; FIBROBLAST; HUMAN; HUMAN CELL; INTRACELLULAR SIGNALING; MIDDLE AGED; PRIORITY JOURNAL; PROTEIN EXPRESSION; STOMACH ADENOCARCINOMA; AGONISTS; ANALOGS AND DERIVATIVES; ANTAGONISTS AND INHIBITORS; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; NEOPLASM; PATHOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

ANTIGENS, CD95; APOPTOSIS; ASPIRIN; CATALASE; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; HYDROGEN PEROXIDE; HYPOCHLOROUS ACID; METALLOPORPHYRINS; NEOPLASMS; NITRATES; NITRIC OXIDE; PEROXYNITROUS ACID; PROTON PUMPS; SIGNAL TRANSDUCTION; SINGLET OXYGEN;

EID: 84940756094     PISSN: 22132317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.redox.2015.07.017     Document Type: Article

References (156)

1. Irani K., Xia Y., Zweier J.L., Sollott S.J., Der C.J., Fearon E.R., Sundaresan M., Finkel T., Goldschmidt-Clermont P.J. Mitogenic signalling by oxidants in Ras-transformed fibroblasts. Science 1997, 275:1649-1652.
2. Irani K., Goldschmidt-Clermont P.J. Biochem. Pharmacol. 1998, 55:1339-1346.
3. Suh Y.-A., Arnold R.S., Lassegue B., Shi J., Xu X., Sorescu D., Chung A.B., Griendling K.K., Lambeth J.D. Cell transformation by the superoxide-generating oxidase Mox1. Nature 1999, 401:79-82.
4. Bittinger F., Gonzalez-Garcia J.L., Lein C.L., Brochhausen C. Offner F und Kirkpatrick CJ: Production of superoxide by human malignant melanoma cells. Melanoma Res. 1998, 8:381-38387.
5. Yang J.Q., Li S., Domann F.E., Buettner G., Oberley L.W. Superoxide generation in v-Ha-ras-transduced human keratinocyte HaCaT cells. Mol. Carcinog. 1999, 26:180-18188.
6. Mitsushita J., Lambeth J.D., Kamata T. The superoxide-generating oxidase nox1 is functionally required for ras oncogenic transformation. Cancer Res. 2004, 64:3580-3585.
7. Laurent E., McCoy J.W., Maccina R.A., Liu W., Cheng G.J., Robine S., Papkoff J., Lambeth J.D. Nox1 is overexpressed in human colon cancers and correlates with activating mutations in K-Ras. Int. J. Cancer 2008, 123:100-10107.
8. Ma Q., Cavallin L.E., Yan B., Zhu S., Duran E.M., Wang H., Hala L.P., Dong C., Cesarman E., Mesri E.A., Goldschmidt-Clermont P.J. Antitumorigenesis of antioxidants in a transgenic Rac1 model of Kaposi's sarcoma. Proc. Natl. Acad. Sci. USA 2009, 106:8683-868688.
9. Kim E.-Y., Seo J.-M., Kim C., Lee J.-E., Lee K.-M., Kim J.-H. BLT2 promotes the invasion and metastasis of aggressive bladder cancer through a reactive oxygen species-linked pathway. Free Rad. Biol. Med. 2010, 49:1072-1081.
10. Du J., Liu J., Smith B.J., Tsao M.S., Cullen J. Role of RAC-1-dependent NADPH oxidase in the growth of pancreatic cancer. Cancer Gene Ther. 2011, 18:135-143.
11. Behrend L., Henderson G., Zwacka R.M. Reactive oxygen species in oncogenic transformation. Biochem. Soc. Trans. 2003, 31:1441-1444.
12. Geiszt M., Leto L. The NOX family of NAD(P)H oxidases: host defense and beyond. J. Biol. Chem. 2004, 279:51715-51718.
13. Bedard K., Krause K.H. The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol. Rev. 2007, 87:245-313.
14. Tominaga K., Kawahara T., Sano t, Toida K., Kuwano Y., Sasaki H., Kawai T. Evidence for cancer-associated expression of NADPH oxidase 1 (Nox1)-base oxidase system in the human stomach. Free Radic. Biol. Med. 2007, 43:1627-1638.
15. Lambeth J.D. Nox enzymes, ROS, and chronic disease: An example of antagonistic pleiotropy. Free Radic. Biol. Med. 2007, 43:332-33347.
16. Lopez-Lazaro M. Excessive superoxide anion generation plays a key role in carcinogenesis. Int. J. Cancer 2007, 120:1378-1380.
17. Kamata T. Roles of Nox1 and other Nox isoforms in cancer development. Cancer Sci. 2009, 100:1382-1388.
18. Weinberg F., Chandel N.S. Reactive oxygen species-dependent signaling regulates cancer. Cell. Mol. Life Sci. 2009, 66:3663-3673.
19. Arnold R.S., Shi J., Murad E., Whalen A.M., Sun C.Q., Palavarapu R., Parthasarathy S., Petros J.A., Lambeth J.D. Hydrogen peroxide mediates the cell growth and transformation caused by the mitogenic oxidase Nox1. Proc. Natl. Acad. Sci. USA 2001, 98:5550-555555.
20. Chamulitrat W., Schmidt R., Tomakidi P., Stremmel W., Chunglok W., Kawahara T., Rokutan K. Association of gp91phox homolog NOX1 with anchorage-independent growth and MAP kinase activation of transformed human keratinocyte. Oncogene 2003, 22:6045-606053.
21. Lopez-Lazaro M. Dual role of hydrogen peroxide in cancer: possible relevance to cancer chemoprevention and therapy. Cancer Lett. 2007, 252:1-8.
22. Jürgensmeier J., Schmitt C.P., Viesel E., Höfler P., Bauer G. TGF-ß-treated normal fibroblasts eliminate transformed fibroblasts by induction of apoptosis. Cancer Res. 1994, 54:393-39398.
23. Jürgensmeier J., Höfler P., Bauer G. TGF-ß-induced elimination of transformed fibroblasts by normal cells: independence of cell-to-cell contact and dependence on reactive oxygen species. Int. J. Oncol. 1994, 5:525-52531.
24. Schaefer D., Jürgensmeier J., Bauer G. Catechol interferes with TGF-ß-induced elimination of transformed cells by normal cells: implications for the survival of transformed cells during carcinogenesis. Int. J. Cancer 1995, 60:520-52526.
25. Langer C., Jürgensmeier J.M., Bauer G. Reactive oxygen species act both at TGF-ß-dependent and -independent steps during induction of apoptosis of transformed cells by normal cells. Exp. Cell Res. 1996, 222:117-124.
26. Hipp M.-L., Bauer G. Intercellular induction of apoptosis in transformed cells does not depend on p53. Oncogene 1997, 15:791-79797.
27. Jürgensmeier J., Bauer G. Interference of Bcl-2 with intercellular control of carcinogenesis. Int. J. Cancer 1997, 71:698-704.
28. Panse J., Hipp M.-L., Bauer G. Fibroblasts transformed by chemical carcinogens are sensitive for intercellular induction of apoptosis: Implications for the control of oncogenesis. Carcinogenesis 1997, 18:259-264.
29. Beck E., Schäfer R., Bauer G. Sensitivity of transformed fibroblasts for intercellular induction of apoptosis is determined by their transformed phenotype. Exp. Cell Res. 1997, 234:47-56.
30. Zucker B., Bauer G. Intercellular induction of apoptosis of transformed cells is modulated by their intracellular glutathione concentration. Int. J. Oncol. 1997, 10:141-14146.
31. Engelmann I., Dormann S., Saran M., Bauer G. Transformed target cell-derived superoxide anions drive apoptosis induction by myeloperoxidase. Redox Rep. 2000, 5:207-214.
32. Herdener M., Heigold S., Saran M., Bauer G. Target cell-derived superoxide anions cause efficiency and selectivity of intercellular induction of apoptosis. Free Radic. Biol. Med. 2000, 29:1260-1271.
33. Schwieger A., Bauer L., Hanusch J., Sers C., Schäfer R., Bauer G. Ras oncogene expression determines sensitivity for intercellular induction of apoptosis. Carcinogenesis 2001, 22:1385-1392.
34. Heigold S., Sers C., Bechtel W., Ivanovas B., Schäfer R., Bauer G. Nitric oxide mediates apoptosis induction selectively in transformed fibroblasts compared to nontransformed fibroblasts. Carcinogenesis 2002, 23:929-92941.
35. Ivanovas B., Bauer G. Selective and nonselective apoptosis induction in transformed and nontransformed fibroblasts by exogenous reactive oxygen and nitrogen species. Anticancer Res. 2002, 22:841-84856.
36. Bauer G. Reactive oxygen and nitrogen species: efficient, selective and interactive signals during intercellular induction of apoptosis. Anticancer Res. 2000, 20:4115-414140.
37. Bauer G., Chatgilialoglu C., Gebicki J.L., Gebicka L., Gescheidt G., Golding B.T., Goldstein S., Kaizer J., Merenyi G., Speier G., Wardman P. Biologically relevant small radicals. Chimia 2008, 62:1-9.
38. Bauer G. Tumor cell protective catalase as a novel target for rational therapeutic approaches based on specific intercellular ROS signaling. Anticancer Res. 2012, 32:2599-2624.
39. Bauer G. Targeting extracellular ROS signaling of tumor cells. Anticancer Res. 2014, 34:1467-1482.
40. Bechtel W., Bauer G. Catalase protects tumor cells against apoptosis induction by intercellular ROS signaling. Anticancer Res. 2009, 29:4541-454557.
41. Bechtel W., Bauer G. Modulation of intercellular ROS signaling of human tumor cells. Anticancer Res. 2009, 29:4559-4570.
42. Heinzelmann S., Bauer G. Multiple protective functions of catalase against intercellular apoptosis-inducing ROS signaling of human tumor cells. Biol. Chem. 2010, 391:675-67693.
43. Steinebach C., Bauer G. An alternative signalling pathway based on nitryl chloride during intercellular induction of apoptosis. In vitro Appl. Mol. Toxicol. 2001, 14:107-120.
44. Schimmel M., Bauer G. Proapoptotic and redox state-related signalling of reactive oxygen species generated by transformed fibroblasts. Oncogene 2002, 21:5886-5896.
45. Deichman G.I., Vendrov E.L. Characteristics of in vitro transformed cells essential for their in vivo survival, selection and metastatic activity. Int. J. Caner 1986, 37:401-40409.
46. Deichman G.I., Kluchareva T.E., Matveeva V.A., Kushlinsky N.E., Bassalyk L.S., Vendrov E.L. Clustering of discrete cell properties essential for tumorigenicity and metastasis. I. Studies of syrian hamster embryo fibroblasts spontaneously transformed in vitro. Int. J. Cancer 1989, 44:904-90907.
47. Deichman G., Matveeva V.A., Kashkina L.M., Dyakova N.A., Uvarova E.N., Nikiforov M.A., Gudkov A.V. Cell transforming genes and tumor progression in vivo unified secondary phenotypic cell changes. Int. J. Cancer 1998, 75:277-283.
48. Deichman G. Natural selection and early changes of phenotype of tumor cells in vivo: Acquisition of new defense mechanisms. Biochemistry 2000, 65:78-94.
49. Deichman G. Early phenotypic changes of in vitro transformed cells during in vivo progression: possible role of the host innate immunity. Sem. Cancer Biol. 2002, 12:317-326.
50. Pottgießer S.J., Heinzelmann S., Bauer G. Intercellular HOCl-mediated apoptosis induction in malignant cells: interplay between NOX1-dependent superoxide anion generation and DUOX-related HOCl-generating peroxidase activity. Anticancer Res. 2015, in press.
51. Candeias L.P., Patel K.B., Stratford M.R.L., Wardmann P. Free hydroxyl radicals are formed on reaction between the neutrophil-derived species superoxide anion and hypochlorous acid. FEBS 1993, 333:151-15153.
52. Folkes L.K., Candeias L.P., Wardman P. Kinetics and mechanisms of hypochlorous acid reactions. Arch. Biochem. Biophys. 1995, 323:120-12126.
53. Scheit K., Bauer G. Direct and indirect inactivation of tumor cell protective catalase by salicylic acid and anthocyanidins reactivates intercellular ROS signaling and allows for synergistic effects. Carcinogenesis 2015, 36:400-40411.
54. Kettle A.J., Winterbourn C.C. A kinetic analysis of the catalase activity of myeloperoxidase. Biochemistry 2001, 40:10204-10212.
55. Connick R.E. The interaction of hydrogen peroxide and hypochlorous acid in acidic solutions containing chloride ion. J. Am. Chem. Soc. 1947, 69:1509-151514.
56. Held A.M., Halko D.J., Hurst J.K. Mechanisms of chlorine oxidation of hydrogen peroxide. J. Am. Chem. Soc 1978, 100:5732-575740.
57. Christensen H., Sehested K., Corfitzen H. Reactions of hydroxyl radicals with hydrogen peroxide at ambient and elevated temperature. J. Phys. Chem. 1982, 86:1588-1590.
58. Moncada S., Higgs E.A. The l-arginine-nitric oxide pathway. New Engl. J. Med 1993, 329:2002-202012.
59. Moncada S., Palmer R.M.J., Higgs E.A. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 1991, 43:109-142.
60. Moncada S., Higgs E.A., Hodson H.F., Knowles R.G., Lopez-Jaramillo P., McCall T., Palmer R.M.J., Radomski W., Rees D.D., Schulz R. The l-arginine: nitric oxide pathway. J Cardiovasc Pharmacol 1991, 17(Suppl. 3):S1-S9.
61. Moncada S., Higgs E.A. Molecular mechanisms and therapeutic strategies related to nitric oxide. The FASEB J 1995, 9:1319-1330.
62. Gardner P.R., Martin L.A., Hall D., Gardner A.M. Dioxygen-dependent metabolism of nitric oxide in mammalian cells. Free Radic. Biol. Med. 2001, 31:191-19204.
63. Hallstrom C.K., Gardner A.M., Gardner P.R. Nitric oxide metabolism in mammalian cells: substrate and inhibitor profiles of a NADPH-cytochrome P450 oxidoreductase-coupled microsomal nitric oxide dioxygenase. Free Radic. Biol. Med. 2004, 37:216-228.
64. Gardner P.R. Assay and characterization of the NO dioxygenase activity of flavohemoglobins. Globins and other nitric oxide-reactive proteins. Methods Enzymol. 2008, 436:217-237.
65. Schmidt K., Mayer B. Consumption of nitric oxide by endothelial cells: Evidence for the involvement of a NAD(P)H-, flavin and heme-dependent dioxygenase reaction. FEBS Lett. 2004, 577:199-204.
66. Goldstein S., Czapski G. Kinetics of nitric oxide autooxidation in aqueous solution in the absence and presence of various reductants. The nature of the oxidizing intermediates. J. Am. Chem. Soc. 1995, 117:12078-1212084.
67. -. Implication for the action of endothelium-derived relaxing factor (EDRF). Free Radic. Res. Commun. 1990, 10:221-22226.
68. Beckman J.S., Beckman T.W., Chen J., Marshall P.A., Freeman B.A. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury form nitric oxide and superoxide. Proc. Natl. Acad. Sci. USA 1990, 87:1620-1624.
69. Koppenol W.H., Moreno J.J., Pryor W.A., Ischiropoulos H., Beckman J.S. Peroxynitrite, a cloaked oxidant formed by nitric oxide and superoxide. Chem. Res. Toxicol. 1992, 5:834-83842.
70. Huie R.E., Padmaja S. The reaction of NO with superoxide. Free Radic. Res. Commun. 1993, 18:195-199.
71. -: a pulse radiolysis study. Free Rad. Biol. Med. 1995, 19:505-50510.
72. Gatti R.M., Alvarez B., Vasquez-Vivar J., Radi R., Augusto O. Formation of spin trap adducts during the decomposition of peroxynitrate. Arch. Biochem. Biophys. 1998, 349:36-46.
73. 2 radicals. Chem. Res. Toxicol. 1998, 11:712-71713.
74. Goldstein S., Meyerstein D., van Eldik R., Czapski G. Peroxynitrous acid decomposes via homolysis: evidence from high-pressure pulse radiolysis. J. Phys. Chem. A 1999, 103:6587-6590.
75. 2: evidence for carbonate radical production. J. Am. Chem. Soc. 1998, 120:3458-3463.
76. Squadrito G.L., Pryor W.A. Oxidative chemistry of nitric oxide: the roles of superoxide, peroxynitrite, and carbon dioxide. Free Radic. Biol. Med. 1998, 25:392-39403.
77. Espey M.G., Miranda K.M., Thomas D.D., Xavier S.A., Citrin D., Vitek M.P., Wink D.A. A chemical perspective on the interplay between NO, reactive oxygen species, and reactive nitrogen species. Ann. N.Y. Acad. Sci. 2002, 962:195-206.
78. Augusto O., Bonini M.G., Amanso A.M., Linares E., Santos C.X., De Menzes S.L. Nitrogen dioxide and carbonate radical anion: two emerging radicals in biology. Free Radic. Biol. Med. 2002, 32:841-84859.
79. De Milito A., Fais S. Tumor acidity, chemoresistance and proton pump inhibitors. Future Oncol. 2005, 1:779-786.
80. Di Mascio P., Bechara E.J.H., Medeiros M.H.G., Briviba K., Sies H. Singlet molecular oxygen production in the reaction of peroxynitrite with hydrogen peroxide. FEBS Lett. 1994, 355:287-289.
81. Goldstein S., Czapski G. Formation of peroxynitrite from the nitrosation of hydrogen peroxide by an oxygenated nitric oxide solution. Inorg. Chem. 1996, 35:5935-595940.
82. Brunelli L., Yermilov V., Beckman J.S. Modulation of catalase peroxidatic and catalatic activity by nitric oxide. Free Radic. Biol. Med. 2001, 30:709-714.
83. Gebicka L., Didil J. Catalytic scavenging of peroxynitrite by catalase. Int. J. Inorg. Biochem. 2009, 103:1375-1379.
84. Wink D.A., Mitchell J.B. Chemical biology of nitric oxide: insights into regulatory, cytotoxic, and cytoprotective mechanisms of nitric oxide. Free Radic. Biol. Med. 1998, 25:434-43456.
85. Bauer G., Zarkovic N. Revealing mechanisms of selective, concentration-dependent potentials of 4-hydroxy-2-nonenal to induce apoptosis in cancer cells through inactivation of membrane-associated catalase. Free Radic. Biol. Med. 2015, 81:128-144.
86. Kim Y.S., Han S. Superoxide reactivates nitric oxide-inhibited catalase. Biol. Chem. 2000, 381:1269-1271.
87. Brown G.C. Reversible binding and inhibition of catalase by nitric oxide. Eur. J. Biochem. 1995, 232:188-191.
88. Kono Y., Fridovich I. Superoxide radical inhibits catalase. J. Biol. Chem. 1982, 257:5751-575754.
89. Shimizu N., Kobayashi K., Hayashi K. The reaction of superoxide radical with catalase. Mechanism of the inhibition of catalase by superoxide radical. J. Biol. Chem. 1984, 259:4414-444418.
90. Fridovich I. Biological effects of the superoxide radical. Arch. Biochem. Biophys. 1986, 247:1-11.
91. .- with catalase and its compound I. Int. J. Radiat. Biol. 1989, 55:45-50.
92. Pigeolet E., Corbisier P., Houbion A., Lambert D., Michiels C., Raes M., Zachary M.-D., Remacle J. Glutathione peroxidase, superoxide dismutase, and catalase inactivation by peroxides and oxygen derived free radicals. Mech. Ageing Dev. 1990, 51:283-297.
93. Lardinois O.M. Reactions of bovine liver catalase with superoxide radicals and hydrogen peroxide. Free Radic. Res. 1995, 22:251-25274.
94. Bauer G. HOCl-dependent singlet oxygen and hydroxyl radical generation modulate and induce apoptosis of malignant cells. Anticancer Res. 2013, 33:3589-3602.
95. Böhm B., Heinzelmann S., Motz M., Bauer G. Extracellular localization of catalase is associated with the transformed state of malignant cells. Biol. Chem. 2015, in press. 10.1515/hsz-2014-0234.
96. Sandstrom P.A., Buttke T.M. Autocrine production of extracellular catalase prevents apoptosis of the human CEM T-cell line in serum-free medium. Proc. Natl. Acad. Sci. USA 1993, 90:4708-474712.
97. Moran E.C., Kamiguti A.S., Cawley J.C., Pettitt A.R. Cytoprotective antioxidant activity of serum albumin and autocrine catalase in chronic lymphatic leukaemia. Br. J. Haematol. 2002, 116:316-328.
98. Elwood P.C., Gallagher A.M., Duthie G.G., Mur L.A.J., Morgan G. Aspirin, salicylates, and cancer. Lancet 2009, 373:1301-131309.
99. Aas A.T., Tønnessen T.I., Brun A., Salford L.G. Growth inhibition of rat glioma cells in vitro and in vivo by aspirin. J. Neuro-Oncol. 1995, 24:171-17180.
100. Bellosillo B., Pique M., Barragan M., Dastano E., Villamor N., Colomer D., Montserrat E., Pons G., Gil J. Aspirin and salicylate induce apoptosis and activation of caspases in B-cell chronic lymphocytic leukemia cells. Blood 1998, 4:1406-141414.
101. Klampfer L., Cammenga J., Wisniewski H.-G., Nimer S.D. Sodium salicylate activates caspases and induces apoptosis of myeloid leukemia cell lines. Blood 1999, 93:2386-2394.
102. Chung Y.M., Bae Y.S., Lee S.Y. Molecular ordering of ROS production, mitochondrial changes, and caspase activation during sodium salicylate-induced apoptosis. Free Radic. Biol. Med. 2003, 34:434-43442.
103. Battaglia V., Salvi M., Toninello A. Oxidative stress is responsible for mitochondrial permeability transition induction by salicylate in liver mitochondria. J. Biol. Chem. 2005, 280:33864-33872.
104. Elder D.J.E., Hague A., Hicks D.J., Paraskeva C. Differential growth inhibition by the aspirin metabolite salicylate in human colorectal tumor cell lines: enhanced apoptosis in carcinoma and in vitro-transformed adenoma relative to adenoma cell lines. Cancer Res. 1996, 56:2273-2276.
105. Hou D.-X., Fujii M., Terahara N., Yoshimote M. Molecular mechanisms behind the chemopreventive effects of anthocyanidins. J. Biomed. Biotechnol. 2004, 2004(5):321-325.
106. Chang Y.-C., Huang H.-P., Hsu J.-D., Yang S.-F., Wang C.-J. Hibiscus anthocyanins rich extract-induced apoptotic cell death in human promyelocytic leukemia cells. Toxicol. Appl. Pharmacol. 2005, 205:201-20212.
107. Chen P.-N., Chu S.-C., Chiou H.-L., Chiang C.-L., Yang S.-F., Hsieh Y.-S. Cyanidin 3-glucoside and peonidin 3-glucoside inhibit tumor cell growth and induce apoptosis in vitro and suppress tumor growth in vivo. Nutr. Cancer 2005, 53:232-23243.
108. Shih P.-H., Yeh C.-T., Yen G.-C. Effects of anthocyanidin on the inhibition of proliferation and induction of apoptosis in human gastric adenocarcinoma cells. Food Chem. Toxicol. 2005, 43:1557-1566.
109. Feng R., Ni H.-M., Wang S.Y., Tourkova I.L., Shurin M.R., Harada H. Cyanidin-3-rutinoside, a natural polyphenol antioxidant, selectively kills leukemic cells by induction of oxidative stress. J. Biol. Chem. 2007, 282:13468-13476.
110. Reddivari L., Vanamala J., Chintharlapalli S., Safe S.H., Creighton J.C. Anthocyan fraction from potato extracts is cytotoxic to prostate cancer cells through activation of caspase-dependent and caspase-independent pathways. Carcinogenesis 2007, 28:2227-2235.
111. Wang l-S., Stoner G.D. Anthocyanins and their role in cancer prevention. Cancer Lett. 2008, 269:281-28290.
112. Rao C.V., Rivenson A., Simi B., Zang E., Van Kelloff G.Steele, Reddy B.S. Chemoprevention of colon carcinogenesis by sulindac, a non-steroidal anti-inflammatory agent. Cancer Res. 1995, 55:1464-1472.
113. Giardiello F.M., Offerhaus G.J.A., DjuBois R.N. The role of non-steroidal anti-inflammatory drugs in colorectal cancer prevention. Eur. J. Cancer 1995, 31A:1071-1076.
114. Thun M.J., Namboodiri M.M., Heath C.W. Aspirin use and reduced risk of fatal colon cancer. New Engl. J. Med. 1991, 325:1593-1596.
115. Harris R.E., Namboodiri K.K., Farrar W.B. Nonsteroidal anti.inflammatory drugs and breast cancer. Epidemiology 1996, 7:203-205.
116. Rothwell P.M., Fowkes F.G.R., Belch J.F.F., Ogawa H., Warlow C.P., Meade T.W. Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials. Lancet 2011, 377:31-41.
117. Rothwell P.M., Price J.F., Fowkes F.G.R., Zanchetti A., Roncaglioni M.C., Tognoni G., Lee R., Belch J.F.F., Wilson M., Mehta Z., Meade T.W. Short-term effects of daily aspirin on cancer incidence mortality, and non-vascular death: analysis of the time course of risks and benefits in 51 randomised controlled trials. Lancet 2012, 379:1602-161612.
118. Hanif R., Pittas A., Feng Y., Koutsos M.I., Qiao L., Staiano-Coico L., Shiff S.I., Rigas B. Effects of nonsteriodal antiinflammatory drugs on proliferation and on induction of apoptosis in colon cancer cells by a prostaglandin-independent pathway. Biochem. Pharmacol. 1996, 52:237-245.
119. Rigas B., Shiff S.I. Is inhibition of cyclooxygenase required for the chemopreventive effect of NSAIDs in colon cancer? A model reconciling the current contradiction. Med. Hypotheses 2000, 54:210-215.
120. Durner J., Klessig D.F. Salicylic acid is a modulator of tobacco and mammalian catalases. J. Biol. Chem. 1996, 271:28492-28501.
121. Escobar J.A., Rubio A., Lissi E.A. SOD and catalase inactivation by singlet oxygen and peroxyl radicals. Free Radic. Biol. Med. 1996, 20:285-290.
122. Kim Y.K., Kwon O.J., Park J.-W. Inactivation of catalase and superoxide dismutase by singlet oxygen derived from photoactivated dye. Biochimie 2001, 83:437-444.
123. Zhuang S., Demir J.T., Kochevar I.E. Protein kinase C inhibits singlet oxygen-induced apoptosis by decreasing caspase-8 activation. Oncogene 2001, 20:6764-676776.
124. Suzuki Y., Ono Y., Hirabayashi Y. Rapid and specific reactive oxygen species generation via NADPH oxidase activation during FAS-mediated apoptosis. FEBS Lett. 1998, 425:209-212.
125. Reinehr R., Becker S., Eberle A., Grether-Beck S., Häussinger D. Involvement of NADPH oxidase isoforms and src family kinases in CD95-dependent hepatocyte apoptosis. J. Biol. Chem 2005, 280:27179-2727194.
126. Riethmüller M., Burger N., Bauer G. Singlet oxygen treatment of tumor cells triggers extracellular singlet oxygen generation, catalase inactivation and reactivation of intercellular apoptosis-inducing signaling. Redox Biol. 2015, 157-168.
127. Scheit K., Bauer G. Synergistic effects between catalase inhibitors and modulators of nitric oxide metabolism on tumor cell apoptosis. Anticancer Res. 2014, 34:5337-535350.
128. Bauer G., Bereswill S., Aichele P., Glocker E. Helicobacter pylori protects protects oncogenically transformed cells from reactive oxygen species-mediated intercellular induction of apoptosis. Carcinogenesis 2014, 35:1582-1591.
129. Lissat A., Vraetz T., Tsokos M., Klein R., Braun M., Koutelia N., Fisch P., Romero M.E., Long L., Noelke P., Mackall C.L., Niemeyer C.M., Kontny U. Interferon-γ sensitizes resistant Ewing's sarcoma cells to tumor necrosis factor apoptosis-inducing ligand-induced apoptosis by up-regulation of caspase-8 without altering chemosensitivity. Am. J. Pathol. 2007, 176:1917-191930.
130. Kerr J.F.R., Wyllie A.H., Currie A.R. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer 1972, 26:239-257.
131. Elmore S. Apoptosis: A review of programmed cell death. Toxicol. Pathol. 2007, 35:495-49515.
132. Temme J., Bauer G. Low-dose gamma irradiation enhances superoxide anion production by nonirradiated cells through TGF-β1-dependent bystander signaling. Radiat. Res. 2013, 179:422-42432.
133. Rigas B., Kashfi K. Nitric oxide-donating NSAIDs as agents for cancer prevention. Trends Mol. Med. 2004, 10:324-330.
134. Tesei A., Rosetti M., Ulivi P., Fabbri F., Medri L., Vannini I., Bolla M., Amadori D., Zoli W. Study of the molecular mechanism of pro-apoptotic activity of NCX 4040, a novel nitric oxide-releasing aspirin, in colon cancer cell lines. J. Transl. Med. 2007, 5:52-62.
135. Feig D.I., Reid T.M., Loeb L.A. Reactive oxygen species in tumorigenesis. Cancer Res. 1994, 54:1890-1894.
136. Storz P. Reactive oxygen species in tumor progression. Front. Biosci. 2005, 10:1881-1896.
137. Chiera F., Meccia E., Degan P., Aquilina G., Pietraforte D., Minetti M., Lambeth D., Bignami M. Overexpression of human NOX1 complex induces genome instability in mammalian cells. Free Radic. Biol. Med. 2008, 44:332-33342.
138. Cerutti P.A. Prooxidant states and tumor promotion. Science 1985, 227:375-381.
139. Shinohara M., Shang W.-H., Kubodera M., Hanada S., Mitsushita J., Kato M., Miyazaki H., Suminoto H., Kamata T. Nox1 redox signaling mediates oncogenic Ras-induced disruption of stress fibers and focal adhesions by down-regulating Rho. J. Biol. Chem. 2007, 282:17640-17648.
140. Sadok A., Bourgarel-Rey V., Gattacceca F., Penel C., Lehmann M., Kovacic H. Nox1-dependent superoxide production controls colon adenocarcinoma cell migration. Biochem. Biophys. Acta 2008, 1783:23-33.
141. Arbiser J.L., Petros J., Klafter R., Govindajaran B., McLaughlin E.R., Brown L.F., Cohen C., Moses M., Kilroy S., Arnold R.S., Lambeth J.D. Reactive oxygen generated by Nox1 triggers the angiogenic switch. Proc. Acad. Natl. Acad. Sci. USA 2002, 99:715-71720.
142. Blanchetot C., Boonstra J. The ROS-NOX connection in cancer and angiogenesis. Crit. Rev. Euk. Gene Expr. 2008, 18:35-45.
143. Ferraro D., Corso S., Fasano E., Panieri E., Santangelo R., Borrelo S., Giordano S., Pani G., Galeotti T. Pro-metastatic signaling by c-Met through Rac-1 and reactive oxygen species. Oncogene 2006, 25:3689-3698.
144. Lopez-Lazaro M. Why do tumors metastasize?. Cancer Biol. Ther. 2007, 6:141-14144.
145. Thomsen L.L., Lawton F.G., Knowles R.G., Beesley J.E., Riveros-Moreno V., Moncada S. Nitric oxide synthase activity in human gynecological cancer. Cancer Res. 1994, 54:1352-1354.
146. Thomsen L.L., Miles D.W., Happerfiel L., Bobrow L.G., Knowles R.G., Moncada S. Nitric oxide synthase in human breast cancer. Br. J. Cancer 1995, 72:41-44.
147. Thomsen L.L., Scott J.M.J., Topley P., Knowles R.G., Keerie A.-J., Frend A. Selective inhibition of inducible nitric oxide synthase inhibits tumor growth in vivo: Studies with 1400W, a novel inhibitor. Cancer Res. 1997, 57:3300-333304.
148. Thomsen L.L., Miles D.W. Role of nitric oxide in tumor progression: lessons form human tumors. Cancer Metastasis Rev. 1998, 17:107-118.
149. Jenkins D.C., Charles I.G., Baylis S.A., Lelchuk R., Radomski M.W., Moncada S. Human colon cancer cell lines show a diverse pattern of nitric oxide synthase gene expression and nitric oxide generation. Br. J. Cancer 1994, 70:847-84849.
150. Jenkins D.C., Charles I.G., Thomsen L.L., Moss D.W., Holmes L.S., Baylis S.A., Rhodes P., Westmore K., Emson P.C., Moncada S. Roles of nitric oxide in tumor growth. Proc Natl. Acad. Sci. USA 1995, 92:4392-4396.
151. Wink D.A., Vodovotz Y., Laval J., Laval F., Dewhirst M.W., Mitchell J.B. The multifaceted roles of nitric oxide in cancer. Carcinogenesis 1998, 19:711-71721.
152. Wink D.A., Mitchell J.B. Nitric oxide and cancer: an introduction. Free Radic. Biol. Med. 2003, 34:951-95954.
153. Kundrát P., Bauer G., Jacob P., Friedland W. Mechanistic modelling suggests that the size of preneoplastic lesions is limited by intercellular induction of apoptosis in oncogenically transformed cells. Carcinogenesis 2012, 33:253-259.
154. Alvarez B., Denicola A., Radi R. Reaction between peroxynitrite and hydrogen peroxide: Formation of oxygen and slowing of peroxynitrite decomposition. Chem. Res. Toxicol. 1995, 8:859-864.
155. Badway J.A., Karnovsky M.L. Active oxygen species and the functions of phagocytic leukocytes. Annu. Rev. Biochem. 1980, 49:695-69726.
156. Selleri C., Sato T., Raiola A.M., Rotoli B., Young N.S., Maciejewski J.P. Induction of nitric oxide synthase is involved in the mechanism of FAS-mediated apoptosis in hematopoietic cells. Br. J. Hematol. 1997, 99:481-48489.